Eritrea vs Myanmar: Access to anti-retroviral drugs, male
Eritrea
72.0%
in 2024
Myanmar
73.0%
in 2024
Eritrea rank
65th
Myanmar rank
62nd
Access to anti-retroviral drugs, male over time
- Eritrea
- Myanmar
How they compare
Myanmar currently reports 73.0% against 72.0% in Eritrea, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Myanmar ahead.
Eritrea ranks 65th and Myanmar ranks 62nd of 141 countries.
Across the 3 decades both report, Eritrea averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | Eritrea | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.3% | 2.2% | 4.1% | Eritrea |
| 2010s | 52.7% | 34.8% | 17.9% | Eritrea |
| 2020s | 69.8% | 71.2% | 1.4% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Eritrea or Myanmar?
- Myanmar, at 73.0% against 72.0% in Eritrea as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Eritrea and Myanmar?
- 1.0%, with Myanmar ahead.
- How many years of comparable data are there for Eritrea and Myanmar?
- 25 years are reported by both, from 2000 to 2024.
- How do Eritrea and Myanmar rank globally for access to anti-retroviral drugs, male?
- Eritrea ranks 65th and Myanmar ranks 62nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.